Resolution of severe MMF-related gastrointestinal adverse events following conversion to enteric-coated mycophenolate sodium.
Suwelack
Barbara
B
Gabriels
Gert
G
Volmer
Sabine
S
Hillebrand
Uta
U
Hohage
Helge
H
Pohle
Thorsten
T
D000328:Adult; D005500:Follow-Up Studies; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology; D008297:Male; D009173:Mycophenolic Acid / Q000008:administration & dosage* / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000494:pharmacology*; D013276:Stomach Ulcer / Q000139:chemically induced* / Q000473:pathology*
D009173:Mycophenolic Acid